Five late-breaking presentations at TCT 2022 highlight the impact of Abbott s structural heart devices to repair or replace heart valves and close openings in the heartNew data reinforce the safety.
Letters sent today by the FDA and Abbott Vascular, the device manufacturer, warn about an increase in reports that the device s clip lock can malfunction.